Omada Health (NASDAQ:OMDA) CEO Sean Duffy Sells 14,158 Shares

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 14,158 shares of the stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $20.00, for a total transaction of $283,160.00. Following the completion of the sale, the chief executive officer owned 394,603 shares of the company’s stock, valued at approximately $7,892,060. The trade was a 3.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Omada Health Stock Performance

Shares of NASDAQ OMDA opened at $20.89 on Friday. The firm has a market cap of $1.24 billion and a price-to-earnings ratio of -77.37. The business’s 50-day simple moving average is $16.51 and its 200-day simple moving average is $14.85. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, equities research analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Institutional Investors Weigh In On Omada Health

Large investors have recently modified their holdings of the stock. Quarry LP purchased a new position in shares of Omada Health during the 4th quarter valued at $29,000. TD Waterhouse Canada Inc. bought a new stake in shares of Omada Health in the 4th quarter worth approximately $32,000. Raymond James Financial Inc. purchased a new position in shares of Omada Health during the 2nd quarter worth approximately $32,000. Inlight Wealth Management LLC bought a new position in shares of Omada Health during the fourth quarter valued at approximately $45,000. Finally, Strs Ohio grew its holdings in shares of Omada Health by 151.0% during the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock valued at $67,000 after buying an additional 2,567 shares during the last quarter.

Analysts Set New Price Targets

OMDA has been the subject of several analyst reports. JPMorgan Chase & Co. decreased their target price on Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research report on Thursday, March 12th. Canaccord Genuity Group set a $24.00 price objective on Omada Health in a report on Friday, May 8th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Citigroup reissued an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. Finally, BMO Capital Markets lowered their price objective on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Ten research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.